PIK3R3 inhibits cell senescence through p53/p21 signaling

被引:41
|
作者
Chen, Qianzhi [1 ,2 ]
Sun, Xuling [1 ]
Luo, Xuelai [1 ]
Wang, Jing [3 ]
Hu, Junbo [1 ]
Feng, Yongdong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept GI,Canc Res Inst, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Basic Med, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-SUPPRESSOR; UP-REGULATION; CANCER; P21; RB;
D O I
10.1038/s41419-020-02921-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular senescence is a stress response of human cells that removes potentially harmful cells by initiating cell cycle arrest. Inducing senescence of tumor cells may be an effective tumor-inhibiting strategy. In this study we found that PIK3R3 could inhibit the cell senescence of colorectal cancer cells and promote cell proliferation through the p53/p21 signal pathway. PIK3R3 could bind to p53 and inhibit the binding of p53 to the p21 gene promoter region, and thus affecting the transcriptional activity of p21 gene. Our study has provided new evidence of the role of PIK3R3 in p53 regulation and inhibition of PIK3R3 may be one of the potential targets of tumor therapy.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] 14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53
    Lee, Jun-Ho
    Lu, Hua
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 5136 - 5142
  • [32] PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway
    Ibrahim, Sidikjan
    Li, Guodong
    Hu, Fuqing
    Hou, Zhenlin
    Chen, Qianzhi
    Li, Geng
    Luo, Xuelai
    Hu, Junbo
    Feng, Yongdong
    CANCER BIOLOGY & THERAPY, 2018, 19 (03) : 222 - 229
  • [33] RAS-activated PI3K/AKT signaling sustains cellular senescence via P53/P21 axis in experimental models of psoriasis
    Mercurio, Laura
    Bailey, Jacob
    Glick, Adam Bleier
    Dellambra, Elena
    Scarponi, Claudia
    Pallotta, Sabatino
    Albanesi, Cristina
    Madonna, Stefania
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2024, 115 (01) : 21 - 32
  • [34] Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma
    Koljonen, V
    Tukiainen, E
    Haglund, C
    Böhling, T
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2209 - 2212
  • [35] The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
    H Okumura
    S Natsugoe
    M Matsumoto
    Y Mataki
    H Takatori
    S Ishigami
    S Takao
    T Aikou
    British Journal of Cancer, 2005, 92 : 284 - 289
  • [36] The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
    Okumura, H
    Natsugoe, S
    Matsumoto, M
    Mataki, Y
    Takatori, H
    Ishigami, S
    Takao, S
    Aikou, T
    BRITISH JOURNAL OF CANCER, 2005, 92 (02) : 284 - 289
  • [37] JNK inhibitor IX restrains pancreatic cancer through p53 and p21
    Shi, Jingwei
    Yang, Xing
    Kang, Qi
    Lu, Jian
    Denzinger, Maximilian
    Kornmann, Marko
    Traub, Benno
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Association of p53 and p21 polymorphisms with prostate cancer
    Sivonova, Monika Kmetova
    Vilckova, Marta
    Kliment, Jan
    Mahmood, Silvia
    Jurecekova, Jana
    Dusenkova, Svetlana
    Waczulikova, Iveta
    Slezak, Peter
    Dobrota, Dusan
    BIOMEDICAL REPORTS, 2015, 3 (05) : 707 - 714
  • [39] Immunohistochemical study of p53, p21 and PCNA in pterygium
    Ueda, Y
    Kanazawa, S
    Kitaoka, T
    Dake, Y
    Ohira, A
    Ouertani, AM
    Amemiya, T
    ACTA HISTOCHEMICA, 2001, 103 (02) : 159 - 165
  • [40] The Role of p21 and p53 Proteins in Congenital Cholesteatoma
    Olszewska, Ewa
    Rutkowska, Justyna
    Minovi, Amir
    Sieskiewicz, Andrzej
    Rogowski, Marek
    Dazert, Stefan
    OTOLOGY & NEUROTOLOGY, 2013, 34 (02) : 266 - 274